June 17, 2025

Ginger Nicol: WashU’s Psychedelic Research – Seeing the Mind in Real Time

Episode #13
“We need psychedelics now more than ever.”

Subscribe On

Ginger Nicol: WashU’s Psychedelic Research – Seeing the Mind in Real Time

Episode 13

Share this:

In healthcare, we are trying to fix what's broken, not prevent the break. Leo and I have thought a lot about, how do we prevent the break?... Psychedelics is not just a medication. It's a whole process, and it needs to be timed. We know that. And so that's one of the things that we. A big challenge that we have is trying to figure out how to bring the different parts of the healthcare system together in concert in a window of time when it's most effective and at the time when the patient needs it the most, to the patients that need it the most.

Show Summary

In this groundbreaking episode of Life Beyond Loss, we sit down with Dr. Ginger Nicol, a leading psychiatrist and psychedelic researcher at Washington University in St. Louis. Dr. Nicol takes us inside her team’s revolutionary work using advanced brain imaging to study consciousness during peak psychedelic experiences. She shares how her research is revealing the biological mechanisms behind psilocybin’s rapid antidepressant effects, including the discovery that new neural connections persist for weeks after treatment. From scanning brains during mystical experiences to developing precision medicine approaches for treatment-resistant depression and PTSD, Dr. Nicol explains how WashU has become a global leader in psychedelic science.

This episode is essential listening for anyone interested in the future of mental health treatment, consciousness research, or cutting-edge neuroscience. Mental health professionals, researchers, patients struggling with treatment-resistant conditions, and curious minds will gain deep insights into how psychedelic therapy actually works in the brain and what makes it so different from traditional psychiatric medications. Listeners will come away understanding the rigorous scientific process behind psychedelic research, how to potentially participate in clinical trials, and why this field represents one of the most promising frontiers in treating depression, PTSD, chronic pain, and other challenging conditions that have long resisted conventional treatment approaches.

Guest Information

Ginger Nichol Headshot

Ginger Nicol, MD

Psychiatrist & Psychedelic Researcher

Links From the Episode

Support Our Sponsors

Krey Distributing

Krey Distributing sets the standard for responsibility by actively promoting safe and responsible alcohol consumption through comprehensive education and community initiatives. Their unwavering commitment to safety and accountability ensures that they lead the way in fostering a culture of mindful, responsible drinking.

Bound Hat Co.

Bound Hat Co. combines style with purpose, crafting premium hats that not only look great but give back to meaningful causes. Every purchase helps support initiatives that make a real impact, so you can wear your values with pride.

Chapter Markers

‍ Introduction & Background (00:00 – 05:39)

  • Dr. Ginger Nicol shares her journey from medical school in Iowa to 20 years at WashU, focusing on psychiatry and research.
  • WashU’s reputation in biological psychiatry and neuroscience attracted Dr. Nicol, leading to a career in research and clinical trials.
  • Interest in psychedelics emerged due to their unique, rapid effects and the opportunity to study consciousness and brain function in real time.

Regulatory Hurdles & Study Launch (05:39 – 07:07)

  • Regulatory challenges for psychedelic research in the US delayed study start; initial approval process began in 2018, but the pandemic caused a two-year delay.
  • First clinical trial using psilocybin and neuroimaging was completed and published in the past summer, marking a new phase for the lab’s work.

Motivation & Societal Need (07:07 – 10:06)

  • Team is driven by both scientific curiosity and the urgent need to address mental health crises, including suicide and workforce shortages.
  • Psychedelics are seen as a tool for both alleviating suffering and understanding consciousness, spirituality, and brain connectivity.
  • Emphasis on balancing research pace with safety and thoroughness, prioritizing impactful questions and participant well-being.

Innovative Neuroimaging & Study Design (10:06 – 17:56)

  • Adoption of precision functional mapping in MRI to capture repeated measures within individuals, increasing statistical power and reducing variability.
  • Study included scanning participants during peak psychedelic experiences, which required extensive preparation and adaptation to the MRI context.
  • Findings showed persistent changes in brain connectivity for up to three weeks post-experience, even in healthy individuals, suggesting neuroplasticity.

Research Focus & Future Directions (17:56 – 22:38)

  • Current focus is on depression, anxiety, and overlapping conditions such as PTSD, OCD, addiction, and chronic pain, especially in vulnerable populations (veterans, essential workers, older adults).
  • Interest in the potential for psychedelics to address both brain and systemic inflammation, with implications for emotional and physical healing.
  • Caution against premature or unsafe use; ongoing work to identify who benefits most and who may be at risk for adverse experiences.

Therapeutic Process & Integration (22:38 – 29:51)

  • Research explores how context, narrative, and therapeutic support influence the efficacy of rapid-acting treatments like ketamine and psychedelics.
  • Importance of post-experience integration, narrative building, and guided support to consolidate new brain connections and perspectives.
  • Comparison to physical therapy: just as rehabilitation requires guidance through necessary pain, psychedelic therapy requires skilled guides to distinguish between productive and harmful discomfort.

Healer Vulnerability & Workforce Development (29:51 – 31:29)

  • Discussion on the importance of supporting and training guides/therapists, acknowledging their own vulnerabilities and the need for a resilient, healthy workforce.
  • Psychedelics present an opportunity to reform mental health care by valuing healer well-being and encouraging more people to become healers.

Precision Psychiatry & Measurement (31:29 – 34:12)

  • Healthy Mind Lab aims to develop precision clinical trials, leveraging advanced imaging and digital health tools to track mood and treatment effects in real time.
  • Plans to validate and simplify complex measures (e.g., EEG, TMS) for broader clinical use, honoring participant contributions while making research scalable.

Scaling Studies & Biotyping (34:12 – 37:04)

  • Next-phase studies will involve hundreds of participants to refine biotypes for depression and other conditions, integrating genetic, imaging, and behavioral data.
  • Goal is to match patients to optimal treatments (e.g., ketamine, psilocybin, MDMA) based on biological and clinical profiles.

Upcoming PET Imaging & Neuroplasticity Research (37:04 – 38:36)

  • New PET imaging study planned to identify neuroplasticity markers in the brain after psilocybin administration, aiming for a 2025 start.
  • WashU’s interdisciplinary team leverages diverse expertise to publish and interpret findings, with a focus on translating research into real-world healing.

Collaborative Implementation & Policy (38:36 – 41:29)

  • Emphasis on collaborative intervention planning, bringing together healthcare, policy, and community stakeholders to address systemic barriers and optimize psychedelic therapy implementation.
  • Recognition of the need for systemic change in healthcare delivery, prevention, and timing of interventions.

️ Legislative Reform & Community Engagement (41:29 – 47:53)

  • States moving toward decriminalization and legislative reform are beginning to allocate funding for research and task forces focused on safety and efficacy.
  • Implementation science is used to simultaneously advance research and treatment, adapting as new data and policy changes emerge.
  • Community networks and advocacy are critical for informing policy and research priorities.

Public Interest & Study Participation (47:53 – 53:33)

  • Growing public curiosity and demand for participation in psychedelic studies; WashU is expanding infrastructure and creating a participant registry and website for community engagement.
  • Plans for community outreach events and educational resources to foster dialogue and inform the public about research opportunities.

Integrating Tribal Knowledge & Clinical Research (53:33 – 59:23)

  • Acknowledgement of the value of indigenous and community-based knowledge in shaping clinical research and therapy models.
  • Commitment to collaborative learning, dialogue, and inclusion of diverse perspectives in developing effective, culturally sensitive psychedelic therapies.

️ Closing Remarks & Call to Action (59:23 – 01:00:04)

  • Gratitude expressed for the research being conducted at WashU and its potential global impact.
  • Encouragement for continued dialogue, community involvement, and destigmatization of mental health and psychedelic therapies.

Help Is Available

If you’re facing mental health struggles, emotional distress, alcohol or drug use concerns, or just need someone to talk to, call or text 988.

Caring counselors are there for you. You are not alone.

Episodes By Category

  • All
  • Distracted Driving
  • EMDR
  • EMT
  • Father
  • Firefighter
  • First Responder
  • Grief
  • Infant Loss
  • Military
  • Mother
  • Podcast
  • Preview
  • Psychedelics
  • Research
  • Sister
  • Suicide
  • Therapist
  • Trauma
  • Washington University
  • Widow

Ginger Nicol: WashU’s Psychedelic Research – Seeing the Mind in Real Time

Leo Cabassa: Confronting Disparities to Provide World Class Healthcare for All

Cover Art for Rebecca Lester's Episode

Rebecca Lester: Ancient Wisdom Meets Modern Research

Melissa Wandall cover art

Melissa Wandall: Raising Resilience – A Mother’s Sacred Promise

Eric Rios: Losing a Son, Finding a Way – A Father’s Healing Journey

Sara Joern Cover Art

Sara Joern: Boundaries Are Love – A Therapist’s Journey of Loss and Healing

Recent Episodes

Ginger Nicol: WashU’s Psychedelic Research – Seeing the Mind in Real Time

June 17, 2025

In healthcare, we are trying to fix what’s broken, not prevent the break. Leo and I have thought a lot about, how do we prevent the break?… Psychedelics is not just a medication. It’s a whole process, and it needs to be timed. We know that. And so that’s one of the things that we. A big challenge that we have is trying to figure out how to bring the different parts of the healthcare system together in concert in a window of time when it’s most effective and at the time when the patient needs it the most, to the patients that need it the most.

Leo Cabassa: Confronting Disparities to Provide World Class Healthcare for All

June 12, 2025

“I worry that if this gets FDA approved then there’s a whole other aspect of the commercialization beyond people that need it. The people who’ve gone, who have the means, is this going to create another inequity where if you have the means, you had access to this treatment. If you don’t, this is not available to you.”

Cover Art for Rebecca Lester's Episode

Rebecca Lester: Ancient Wisdom Meets Modern Research

June 10, 2025

In our society, we think of psychedelics as drugs that are illegal for the most part, and, you know, dangerous… but through the span of human history, they’ve been part of our culture. These kinds of compounds grow all over the world. And so humans for millennia have been utilizing them for medicinal reasons, for ritual reasons, for religious reasons. For most of human history, they’ve been very accepted as part of our healing systems.

Melissa Wandall cover art

Melissa Wandall: Raising Resilience – A Mother’s Sacred Promise

March 4, 2025

The EMTs allowed me to go say goodbye to my husband. And when I did, I promised. I thanked him, number one, for our life. I thanked him for the best five years of my life. And I promised him that I would take care of our family and that our baby would be a happy baby and that she would be born into love and light and not tragedy and negativity.

New Episodes

New episodes are released each week.

Follow Us

Facebook Youtube Instagram

Be a Guest

Contact
Scroll to Top